Skip to main content

03 July 2019

The global prevalence of erectile dysfunction

A review of studies recently published in BJU International journal by King’s researchers found that estimates for the global prevalence of erectile dysfunction vary widely.

Close up of doctor with clipboard and stethoscope
Close up of doctor with clipboard and stethoscope

Erectile dysfunction is linked with increased risks of cardiovascular disease, dementia, and early death and affects up to one in five men (4.3 million men) across the UK. It is estimated that by 2025, 322 million men worldwide will be affected by it.

The estimates discovered, ranging from 3% to 76.5% may reflect differences in study population ages and different definitions and assessment methods of erectile dysfunction.

The authors noted that early detection may help improve the quality of life in affected men and also indicate when interventions may be warranted to prevent cardiovascular disease and early death. “Due to the sensitive nature of the topic, physicians should consider screening for erectile dysfunction in at-risk patients, as information may not be volunteered.”

Lead author, Dr Mieke Van Hemelrijck, School of Cancer & Pharmaceutical Sciences at King’s said:

“Quality of Life is now an important area of research in medicine. Hence, there is a need to recognize the prevalence and consequences of erectile dysfunction, as to allow better support and interventions for these men.”

Read the review in BJU International journal of Urology here.